Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612001246875
Ethics application status
Approved
Date submitted
23/11/2012
Date registered
26/11/2012
Date last updated
17/07/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
Stand Up University of Queensland ('Stand Up UQ'): Reducing sitting time in office workers
Scientific title
Reducing sitting time in office workers: comparison of a multifaceted workplace approach vs. installation of height-adjustable desks only using a three-armed controlled trial
Secondary ID [1] 281576 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Sedentary behaviour 287860 0
Condition category
Condition code
Public Health 288219 288219 0 0
Health promotion/education

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Arm 1:
'High-intensity intervention group', receiving a height-adjustable workstations for 12 months, as well as individual behaviour change coaching during the first 3 months of teh height-adjustable workstation being installed (1x30min face-to-face session delivered once by the project coordinator; 3x10min support phone calls conducted by the project coordinator; written educational self-monitoring materials), and organisational behaviour change intervention elements (1x30min management consultation conducted by the research coordinator; 1x30min staff education session delivered by the research coordinator; and, 3 manager emails provided in template form by the research coordinator and tailored by the manager to the staff team).

Arm 2:
‘Minimal treatment’ intervention group, receiving height-adjustable workstations only for 12 months
Intervention code [1] 286101 0
Behaviour
Intervention code [2] 286105 0
Treatment: Devices
Intervention code [3] 286106 0
Treatment: Other
Comparator / control treatment
Arm 3: No treatment (assessment only with data collected at baseline and 3 months)
Control group
Active

Outcomes
Primary outcome [1] 288412 0
Primary Outcome: Workplace sitting time in minutes per 8-hour work day; measured objectively with activPAL inclinometers
Timepoint [1] 288412 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months
Secondary outcome [1] 300091 0
Other workplace physical activity (standing, moving, sit-to stand transitions) in minutes per 8-hour work day; measured objectively with activPAL inclinometers
Timepoint [1] 300091 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months
Secondary outcome [2] 300092 0
All-of-day sedentary behaviour and light-intensity physical activity in minutes per 16-hour day; measured objectively with activPAL inclinometers
Timepoint [2] 300092 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months
Secondary outcome [3] 300093 0
Anthropometric measures:
Height (nearest 0.1cm) measured in duplicate without shoes using a stadiometer (Seca limited, Germany).
Weight, body water mass, and body fat mass measured using an electronic bio-impedance scale (Soehnle-Waagen GmbH & Co. KG, Germany) with footwear and heavy clothing removed.
Body Mass Index (BMI) was calculated as [average weight (kg)/ average height (m2)].
Waist and hip circumference were measured in duplicate to the nearest 0.1cm using a non-expandable tape measure at the superior border of the iliac crest (Ross et al., 2008) and the greatest gluteal protuberance (Lohman, Martorell, & Roche, 1988), respectively, over one layer of clothing.
Timepoint [3] 300093 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months
Secondary outcome [4] 300094 0
Fasting blood lipids and glucose, assessed using a 35 microliter whole-blood sample via finger stick and a Cholestech LDX Analyser (Hayward, CA) following an overnight fast of at least 8 hours.
Timepoint [4] 300094 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months
Secondary outcome [5] 300095 0
Self-report measures: general demographic information (age, gender, ethnicity, educational attainment, employment history, smoking history and medical history), general health (fatigue, eye strain, headaches, digestion and sleep problems, musculoskeletal health), dietary intake, and work-related (self-rated work performance, absenteeism and presenteeism) user perception, participant feedback, and adverse events were collected via self-report in an online questionnaire.
Timepoint [5] 300095 0
Intervention groups: at baseline, 3 months, and 12 months

Control group: at baseline and 3 months

Eligibility
Key inclusion criteria
Participants are eligible if they speak English, work at least 0.6 FTE in a job primarily involving computer/admin work, and have designated access to the internet and a desk within the workplace.
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Participants are excluded if they
a) are pregnant
b) are non-ambulatory
c) have allergies to medical adhesive (used to attach the activPAL monitor)
d) currently have any physical or health problems (incl. shoulder/back/neck pain or strain) that may limit their ability to regularly stand up or to stand up for at least 10 minutes at a time
e) plan absence from work for >2wks or plan relocation to another worksite during the 12 months-intervention period.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Data analysis is complete
Reason for early stopping/withdrawal
Participant recruitment difficulties
Date of first participant enrolment
Anticipated
30/01/2012
Actual
30/01/2012
Date of last participant enrolment
Anticipated
Actual
30/06/2012
Date of last data collection
Anticipated
Actual
30/03/2013
Sample size
Target
60
Accrual to date
Final
44
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment postcode(s) [1] 6056 0
4006
Recruitment postcode(s) [2] 6057 0
4072
Recruitment postcode(s) [3] 6058 0
4043

Funding & Sponsors
Funding source category [1] 286374 0
Government body
Name [1] 286374 0
Australian Postgarduate Award Scholarship
Country [1] 286374 0
Australia
Funding source category [2] 286375 0
University
Name [2] 286375 0
CPRC top-up scholarship
Country [2] 286375 0
Australia
Funding source category [3] 286376 0
University
Name [3] 286376 0
UQ PhD funding
Country [3] 286376 0
Australia
Funding source category [4] 286377 0
Government body
Name [4] 286377 0
CPRC Equipment Grant
Country [4] 286377 0
Australia
Funding source category [5] 286378 0
Government body
Name [5] 286378 0
CPRC Core Funding
Country [5] 286378 0
Australia
Primary sponsor type
University
Name
Cancer Prevention research Centre
Address
Cancer Prevention Research Centre
School of Population Health
The University of Queensland
Herston Rd
Herston, QLD, 4006
Country
Australia
Secondary sponsor category [1] 285166 0
Individual
Name [1] 285166 0
Maike Neuhaus
Address [1] 285166 0
Cancer Prevention Research Centre
School of Population Health
The University of Queensland
Herston Rd
Herston, QLD, 4006
Country [1] 285166 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 288449 0
SPH Research Ethics Committee
Ethics committee address [1] 288449 0
School of Population Health
The University of Queensland
Herston Rd
Herston, QLD 4006
Ethics committee country [1] 288449 0
Australia
Date submitted for ethics approval [1] 288449 0
18/07/2011
Approval date [1] 288449 0
04/08/2011
Ethics approval number [1] 288449 0
MN010811

Summary
Brief summary
Research over the last decade has shown that less sitting throughout the day is associated with a decreased risk of many chronic conditions such as type 2 diabetes, heart disease, and some cancers. While at work, office workers report high levels of sitting time, mostly due to the nature of their computer and desk based jobs. Height-adjustable workstations may provide a means of reducing sitting time at work. However, the most effective way to introduce such workstations to organisations is yet to be established. That is, whether the installation of height-adjustable workstations alone is sufficient to reduce sitting time in office workers, or whether additional aspects of the workplace (including indiviudual staff and managers, organisational social norms etc) need to be targeted as well. The objective of the Stand Up UQ study was thus to evaluate (in a three-arm study) whether a multifaceted intervention involving height-adjustable desks and organisational and individual behavioral change elements leads to greater reductions in objectively measured workplace sitting when compared to the use of height-adjustable workstations alone (and in comparison to a control group).
Trial website
Trial related presentations / publications
Neuhaus, M., Healy, G.N., Fjeldsoe, B.S., Lawler, S., Owen, N., Dunstan, D.W., LaMontagne, A.D., Eakin, E.G. (2014). Development of ‘Stand Up Australia’ – A multi-component intervention to reduce workplace sitting. International Journal of Behavioral Nutrition and Physical Activity 11:21;

Neuhaus, M., Healy, G.N., Dunstan, D.W., Owen, N., Eakin, E.G. (2014). Workplace Sitting and Height- Adjustable Workstations: A Randomized Controlled Trial. American Journal of Preventive Medicine 46(1):30–40;
Public notes
Only the two intervention groups were followed up again after 12 months.

Contacts
Principal investigator
Name 34975 0
Dr Maike Neuhaus
Address 34975 0
Ground floor, Building 33, Princess Alexandra Hospital, Woolloongabba QLD Australia 4102
Country 34975 0
Australia
Phone 34975 0
+61 7 3176 5314
Fax 34975 0
Email 34975 0
[email protected]
Contact person for public queries
Name 18222 0
Dr Maike Neuhaus
Address 18222 0
Cancer Prevention Research Centre
School of Population Health
The University of Queensland
Herston Rd
Herston, QLD 4006
Country 18222 0
Australia
Phone 18222 0
+61 7 33655528
Fax 18222 0
Email 18222 0
[email protected]
Contact person for scientific queries
Name 9150 0
Dr Maike Neuhaus
Address 9150 0
Cancer Prevention Research Centre
School of Population Health
The University of Queensland
Herston Rd
Herston, QLD 4006
Country 9150 0
Australia
Phone 9150 0
+61 7 33655528
Fax 9150 0
Email 9150 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.